Open AccessLONG-TERM RESULTS OF TARGET THERAPY WITH FIRST AND * SECOND-LINE TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
Author(s) -
L. L. Vysotskaya,
А. К. Голенков,
Е. В. Трифонова,
Т. А. Митина,
Е. В. Катаева,
Yu. B. Chernykh
Publication year - 2016
Publication title -
alʹmanah kliničeskoj mediciny
Language(s) - English
Resource type - Journals
eISSN - 2587-9294
pISSN - 2072-0505
DOI - 10.18786/2072-0505-2015-41-60-65
Subject(s) - myeloid leukemia , tyrosine kinase , medicine , tyrosine kinase inhibitor , term (time) , oncology , cancer research , cancer , receptor , physics , quantum mechanics